VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WGS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WGSGeneDx Holdings Corp.
$69.82$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWGSQuarterly Financials

GeneDx Holdings Corp. (WGS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

GeneDx Holdings Corp. (WGS) quarterly income statement — complete revenue, gross profit & net income history

WGS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue102.25M120.99M116.74M102.69M87.11M95.64M76.87M70.51M62.42M57.42M53.3M48.71M
Revenue Growth %17.38%26.5%51.86%45.63%39.56%66.57%44.22%44.77%44.7%-6.41%-35.96%34.66%
Cost of Goods Sold34.04M42.07M32.22M31.79M28.64M29.43M29.05M27.56M25.01M26.66M28.04M29.95M
COGS % of Revenue33.29%34.77%27.6%30.96%32.87%30.78%37.78%39.09%40.07%46.44%52.61%61.49%
Gross Profit68.21M78.92M84.53M70.9M58.48M66.2M47.83M42.95M37.41M30.75M25.26M18.76M
Gross Margin %66.71%65.23%72.4%69.04%67.13%69.22%62.22%60.91%59.93%53.56%47.39%38.51%
Gross Profit Growth %16.65%19.21%76.73%65.07%56.31%115.27%89.35%128.99%145.54%288.37%86.43%163.37%
Operating Expenses94.39M92.64M87.78M61.94M63.03M57.4M55.61M53.53M51.07M56.4M68.23M70.38M
OpEx % of Revenue92.31%76.57%75.19%60.32%72.35%60.02%72.34%75.92%81.82%98.22%128%144.5%
Selling, General & Admin74.59M74.44M67.95M46.38M50.45M45.03M43.17M42.15M39.5M42.19M42.86M52.52M
SG&A % of Revenue72.95%61.53%58.2%45.17%57.91%47.08%56.16%59.77%63.29%73.47%80.41%107.84%
Research & Development19.8M24.03M19.83M14.87M12.58M11.59M11.66M10.69M11.57M12.25M14.29M17.14M
R&D % of Revenue19.37%19.86%16.99%14.48%14.44%12.12%15.17%15.16%18.53%21.33%26.81%35.19%
Other Operating Expenses0-1000K0688K0785K774K693K01000K1000K718K
Operating Income-57.47M-13.72M-3.25M8.96M-4.55M8.81M-7.78M-10.58M-13.66M-25.64M-42.97M-51.62M
Operating Margin %-56.2%-11.34%-2.78%8.73%-5.22%9.21%-10.12%-15%-21.88%-44.66%-80.61%-105.99%
Operating Income Growth %-1162.82%-255.79%58.21%184.7%66.68%134.34%81.89%79.51%77.37%92.11%52.69%68.26%
EBITDA-57.47M-6.84M3.22M15.15M1.13M14.36M-1.85M-5.36M-8.41M-19.55M-34.3M-41.29M
EBITDA Margin %-56.2%-5.65%2.76%14.75%1.29%15.02%-2.41%-7.6%-13.48%-34.05%-64.34%-84.77%
EBITDA Growth %-5199.47%-147.61%274.12%382.62%113.4%173.48%94.6%87.02%83.74%93.28%57.3%73.13%
D&A (Non-Cash Add-back)06.88M6.47M6.19M5.68M5.56M5.93M5.22M5.25M6.09M8.67M10.33M
EBIT0-17.71M-6.83M11.38M-5.44M8.81M-7.78M-28.47M-19.72M-25.64M-34.69M-51.62M
Net Interest Income0-520K-562K-817K-640K-698K-843K-894K-597K-978K1.05M1.07M
Interest Income00000000001.05M1.7M
Interest Expense-717K520K562K817K640K698K843K894K597K978K0626K
Other Income/Expense-4.95M-4.51M-4.14M1.6M-1.53M-3.39M-579K-18.78M-6.66M-541K509K4.71M
Pretax Income-62.42M-18.23M-7.39M10.56M-6.08M5.41M-8.36M-29.36M-20.32M-26.18M-42.46M-46.91M
Pretax Margin %-61.04%-15.07%-6.33%10.29%-6.98%5.66%-10.87%-41.64%-32.55%-45.6%-79.65%-96.32%
Income Tax-897K-564K247K-246K447K-24K-47K-190K-82K-411K-172K-196K
Effective Tax Rate %1.44%3.09%-3.34%-2.33%-7.35%-0.44%0.56%0.65%0.4%1.57%0.41%0.42%
Net Income-63.32M-17.67M-7.63M10.81M-6.53M5.44M-8.31M-29.17M-20.24M-25.77M-42.29M-46.72M
Net Margin %-61.92%-14.6%-6.54%10.53%-7.49%5.69%-10.81%-41.37%-32.42%-44.89%-79.33%-95.92%
Net Income Growth %-869.77%-424.86%8.14%137.05%67.74%121.1%80.34%37.56%66.82%91.65%45.49%45.51%
Net Income (Continuing)-63.32M-17.67M-7.63M10.81M-6.53M5.44M-8.31M-29.17M-20.24M-25.77M-42.29M-46.72M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-2.16-0.59-0.270.36-0.230.20-0.31-1.10-0.78-0.99-1.64-1.84
EPS Growth %-839.13%-395%12.9%132.73%70.51%120.2%81.1%40.22%74.34%96.23%75.6%78.04%
EPS (Basic)-2.16-0.61-0.270.38-0.230.20-0.31-1.10-0.78-0.99-1.64-1.84
Diluted Shares Outstanding29.34M26.89M28.8M29.75M28.15M26.99M27.1M26.62M26.06M25.98M25.79M25.42M
Basic Shares Outstanding29.34M26.89M28.8M28.58M28.15M26.99M27.1M26.62M26.06M25.98M25.79M25.42M
Dividend Payout Ratio------------